8 10, 2021

Qkine appoints Japanese distribution partner MBL to extend global availability of its innovative stem cell and organoid culture reagents

By |2021-10-08T12:15:37+00:00October 8th, 2021|animal-free, news, organoid news|Comments Off on Qkine appoints Japanese distribution partner MBL to extend global availability of its innovative stem cell and organoid culture reagents

Qkine has concluded a sales distribution agreement with Japanese company, MBL Medical & Biological Laboratories Co., Ltd. MBL have extensive knowledge and presence within the Japanese regenerative medicine and iPSC sector, an important market for Qkine's high purity, animal-free optimised growth factor and cytokine proteins. The two companies share a focus on product quality and the emerging areas of organoid and organ-on-chip technologies for basic research, personalised medicine and drug discovery. This distributor agreement between Qkine and MBL will facilitate access to Qkine's entire range of premium quality, animal-free and novel optimised growth factor proteins across Japan.

Title

Go to Top